ClearPoint Neuro, Inc. (CLPT) faces a bearish outlook due to overvaluation, weak financials, and tough competition in the neurosurgery market. Analysts recommend shorting CLPT with a price target of $6, foreseeing a 50% decline.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing